Skip to content

Comparison of the effects of esketamine and dexmedetomidine on postpartum depression in women with prenatal depression following cesarean section : A prospective randomized controlled study

Comparison of the effects of esketamine and dexmedetomidine on postpartum depression in women with prenatal depression following cesarean section : A prospective randomized controlled study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102830
Enrollment
Unknown
Registered
2025-05-20
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum depression

Interventions

Esketamine group:Following the delivery of the fetus, esketamine was administered at a dose of 0.25 mg/kg mixed in 20 ml of saline via intravenous infusion over a period of 10 minutes. The postoperati
Dexmedetomidine group:Following the delivery of the fetus, dexmedetomidine was administered at a dose of 0.5 ug/kg mixed in 20 ml of saline via intravenous infusion over a period of 10 minutes. The po
Control group:Following the delivery of the fetus, 20 ml of saline via intravenous infusion over a period of 10 minutes. The postoperative intravenous analgesic pump consisted of 100 µg of sufentanil

Sponsors

The First Maternity and Infant Hospital Affiliated to Tongji University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Pregnant women aged 20-45 years, at full-term gestation (> 37 weeks), with an Edinburgh Postnatal Depression Scale (EPDS) score > 9, and scheduled to undergo an elective cesarean section under neuraxial anesthesia.

Exclusion criteria

Exclusion criteria: Patients with a history of mental disorders prior to childbirth; History of psychotropic drug use. Severe obstetric complications, including preeclampsia, eclampsia, gestational hypertension, intracranial hypertension, hyperthyroidism, placenta previa. Intraoperative complications involving severe blood loss (>1000ml), combined organ injuries (intestinal or urinary system injuries). Allergy to NMDA receptor antagonists or dexmedetomidine. Change of anesthesia method ( conversion to general anesthesia). Heart rate below 50 beats per minute or presence of cardiac conduction block or arrhythmia, such as sick sinoatrial node syndrome. Preoperative hypotension (defined as systolic blood pressure < 90mmHg). Refusal to use the postoperative analgesic pump. Individuals unwilling to participate in questionnaire surveys and clinical examinations.

Design outcomes

Primary

MeasureTime frame
incidenceof positive PPD screening results;

Countries

China

Contacts

Public ContactXu Zhendong

Department of Anesthesiology, the First Maternity and Infant Hospital Affiliated to Tongji University

btxzd123@126.com+86 138 1702 9904

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026